We are live on
!
Find out more
BNP Paribas Asset Management Portfolio holdings
AUM
$86.1B
1-Year Est. Return
29.11%
This Fund
S&P 500
This Quarter
Est. Return
-2.17%
1 Year Est. Return
+29.11%
3 Year Est. Return
+87.64%
5 Year Est. Return
+102.48%
10 Year Est. Return
+408.22%
AUM
$86.1B
AUM Growth
-$1.05B
(-1.2%)
Cap. Flow
+$4.86B
Cap. Flow
% of AUM
5.64%
Top 10 Holdings %
Top 10 Hldgs %
27.63%
Holding
2,366
New
101
Increased
1,396
Reduced
686
Closed
108
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$1.43B |
| 2 |
TotalEnergies
TTE
|
+$626M |
| 3 |
Deutsche Bank
DB
|
+$326M |
| 4 |
Stellantis
STLA
|
+$263M |
| 5 |
Broadcom
AVGO
|
+$237M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ciena
CIEN
|
+$291M |
| 2 |
Apple
AAPL
|
+$262M |
| 3 |
Amazon
AMZN
|
+$219M |
| 4 |
Tesla
TSLA
|
+$205M |
| 5 |
Meta Platforms (Facebook)
META
|
+$197M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.22% |
| 2 | Healthcare | 13.97% |
| 3 | Financials | 10.51% |
| 4 | Consumer Discretionary | 10.09% |
| 5 | Industrials | 8.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1001
National Health Investors
NHI
$3.64B
| $2.09M | ﹤0.01% |
25,846
-1,633
| -6% | -$136K |
|
1002
Altria Group
MO
$114B
| $2.09M | ﹤0.01% |
31,648
-26,641
| -46% | -$1.71M |
|
1003
Kratos Defense & Security Solutions
KTOS
$10.4B
| $2.07M | ﹤0.01% |
29,347
+14,569
| +99% | +$1.4M |
|
1004
Alcoa
AA
$12.5B
| $2.07M | ﹤0.01% |
31,136
-10,457
| -25% | -$642K |
|
1005
MillerKnoll
MLKN
$1.64B
| $2.05M | ﹤0.01% |
141,749
-26,615
| -16% | -$523K |
|
1006
Cemex
CX
$16.7B
| $2.04M | ﹤0.01% |
178,644
-28,073
| -14% | -$335K |
|
1007
Fidelity National Financial
FNF
$13.7B
| $2.04M | ﹤0.01% |
44,050
-4,450
| -9% | -$231K |
|
1008
Axos Financial
AX
$5.9B
| $2.02M | ﹤0.01% |
23,754
-440
| -2% | -$40.1K |
|
1009
Organon & Co
OGN
$3.56B
| $2.02M | ﹤0.01% |
336,976
+1,340
| +0.4% | +$10.1K |
|
1010
Nutanix
NTNX
$16.3B
| $2M | ﹤0.01% |
52,741
-588,122
| -92% | -$24.8M |
|
1011
AdaptHealth
AHCO
$943M
| $1.97M | ﹤0.01% |
165,932
+505
| +0.3% | +$5.17K |
|
1012
Blackbaud
BLKB
$2.06B
| $1.97M | ﹤0.01% |
50,921
-11,287
| -18% | -$564K |
|
1013
NRG Energy
NRG
$25.3B
| $1.95M | ﹤0.01% |
13,340
-6,850
| -34% | -$1.08M |
|
1014
MaxCyte
MXCT
$116M
| $1.95M | ﹤0.01% |
2,773,554
| – | – |
|
|
SLNO
1015
DELISTED
Soleno Therapeutics
SLNO
| $1.94M | ﹤0.01% |
57,828
+18,870
| +48% | +$740K |
|
1016
CONMED
CNMD
$1.5B
| $1.94M | ﹤0.01% |
54,742
-309
| -0.6% | -$12.6K |
|
1017
Harmony Biosciences
HRMY
$2.23B
| $1.93M | ﹤0.01% |
69,025
-455
| -0.7% | -$14.9K |
|
1018
Azenta
AZTA
$1.4B
| $1.92M | ﹤0.01% |
90,948
+90,150
| +11,297% | +$2.69M |
|
1019
Guidewire Software
GWRE
$13.2B
| $1.92M | ﹤0.01% |
12,832
+469
| +4% | +$71.4K |
|
1020
Coeur Mining
CDE
$17.9B
| $1.9M | ﹤0.01% |
101,325
+6,109
| +6% | +$133K |
|
1021
Stagwell
STGW
$2.21B
| $1.89M | ﹤0.01% |
300,256
+701
| +0.2% | +$3.92K |
|
1022
Southwest Airlines
LUV
$23.9B
| $1.87M | ﹤0.01% |
49,744
+35,791
| +257% | +$1.62M |
|
1023
Upbound Group
UPBD
$1.19B
| $1.85M | ﹤0.01% |
102,526
+270
| +0.3% | +$5.26K |
|
1024
Tencent Music
TME
$15.5B
| $1.85M | ﹤0.01% |
199,223
-1,635,437
| -89% | -$24.2M |
|
1025
Caesars Entertainment
CZR
$6.11B
| $1.84M | ﹤0.01% |
69,726
+13,675
| +24% | +$325K |
|
Similar funds
BNP Paribas Asset Management's Q1 2026 Portfolio in Review
As of Q1 2026, BNP Paribas Asset Management held 2,366 positions worth $86.1B, down 1.2% from $87.2B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
BNP Paribas Asset Management deployed $4.86B of net new capital in Q1 2026, opening 101 new positions and adding to 1,396 existing holdings. Its largest new stake was Viking Holdings: 1,864,036 shares worth $137M.
By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 37% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Ciena, an estimated $291M trimmed.
- BNP Paribas Asset Management's largest Q1 2026 buy was Viking Holdings: 1,864,036 shares worth $137M.
- BNP Paribas Asset Management added most to AstraZeneca in Q1 2026, an estimated $1.43B increase.
- BNP Paribas Asset Management's biggest Q1 2026 reduction was Ciena, cutting an estimated $291M.
- BNP Paribas Asset Management fully exited Exact Sciences in Q1 2026, selling an estimated $35.9M.
- BNP Paribas Asset Management's ten largest holdings make up 28% of its $86.1B portfolio in Q1 2026.
- BNP Paribas Asset Management opened 101 new positions and closed 108 in Q1 2026.
- BNP Paribas Asset Management's portfolio value fell 1.2% quarter-over-quarter to $86.1B.
Based on BNP Paribas Asset Management's 13F filing for Q1 2026, filed 14 May 2026.